Back to Results
First PageMeta Content
Allergology / Sublingual immunotherapy / Stallergenes / Allergic conjunctivitis / Immunotherapy / Allergy / House dust mite / Allergic rhinitis / Allergen / Medicine / Health / Immunology


Statistical Reviewer: Tammy Massie, PhD STN: [removed]Application Type STN CBER Received Date
Add to Reading List

Open Document

File Size: 4,41 MB

Share Result on Facebook

Company

Intended Population(s) Stallergenes Inc. / Stallergenes SA / /

Continent

Europe / /

Country

Germany / Romania / Hungary / Netherlands / Italy / Estonia / Slovenia / Bulgaria / Cyprus / Latvia / Poland / Belgium / France / United States / Canada / Portugal / Slovakia / Malta / Lithuania / Luxembourg / Spain / Greece / Ireland / Czech Republic / /

Event

FDA Phase / /

IndustryTerm

pharmaceutical / biopharmaceutical / treatment of allergic disease / /

MarketIndex

Curve Body Mass / /

MedicalCondition

Covariance Allergic Rhinitis / conjunctivitis / fatigue / hay fever / asthma / disease / Asthma Global Allergy / allergy / allergic conjunctivitis / runny nose / allergic reactions / allergic rhinitis / /

MedicalTreatment

immunotherapy / /

Organization

Application Type STN CBER Received Date Completion Goal Date Division / Food and Drug Administration / ND NS / NS PP / FDA / European Union / Advisory Committee / /

Person

A. Dale Horne / CID CMH CS CSR DRM / J. Massie / Tammy Massie / Minimal Clinically / Lihan Yan / EMA EU FAS FDA GES / /

Position

statistician / Team Leader / Linear Model International Conference / Branch Chief / Project Manager / officer / Forward / /

Product

BAL / Restricted Maximum Likelihood Rescue Medication / Oralair® / study / Oralair / VO61 / sublingual / /

ProgrammingLanguage

RC / ML / /

ProvinceOrState

Kentucky / Arkansas / /

PublishedMedium

the Statistical Review / /

Region

mid-Atlantic / /

Technology

antibodies / GPS / /

SocialTag